Related Experiment Video
Updated: Dec 18, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
The transitional phase of multiple sclerosis: Characterization and conceptual framework
Ingo Kleiter1, Ilya Ayzenberg2, Joachim Havla3
1Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Abstract:
The conversion of relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) cannot be defined by a sharp threshold determined by event-based measures, but rather represents a gradual process. In consequence, there may exist a transitional phase between RRMS and clearly established SPMS. So far, transitional MS has been poorly characterized in terms of patient properties, course of disease and therapeutic interventions that may delay conversion to SPMS. Furthermore, the pathogenesis of transitional MS is incompletely understood, and no definitive imaging or laboratory test informs when exactly a patient has entered the transitional MS phase. Here we review the current knowledge and evidence characterizing the transitional phase of MS and propose potential designs and criteria for a prospective clinical study in patients with transitional MS.
Insights
The transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is gradual, not abrupt. Further research is needed to define this transitional MS phase and identify interventions to delay progression.
Area of Science:
- Neuroimmunology
- Clinical Neurology
- Disease Progression
Background:
- The conversion from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is a gradual process, lacking a defined threshold.
- A transitional phase between RRMS and SPMS is hypothesized but poorly understood.
- Current understanding of transitional multiple sclerosis (MS) lacks characterization of patient properties, disease course, and therapeutic strategies.
Purpose of the Study:
- To review existing knowledge on the transitional phase of multiple sclerosis.
- To characterize patient properties, disease course, and therapeutic interventions relevant to transitional MS.
- To propose designs and criteria for a prospective clinical study in transitional MS patients.
Main Methods:
- Literature review of current evidence on transitional MS.
- Analysis of patient characteristics and disease progression in the transitional phase.
- Exploration of potential diagnostic markers and therapeutic targets.
Main Results:
- The conversion to SPMS is a continuum, suggesting a distinct transitional MS phase.
- Transitional MS is poorly defined regarding clinical features, pathogenesis, and diagnostic markers.
- Evidence for interventions delaying RRMS to SPMS conversion in this phase is limited.
Conclusions:
- The transitional phase of MS requires further investigation to improve patient management.
- Prospective studies are essential to define transitional MS and identify effective treatments.
- Better characterization of transitional MS could lead to earlier diagnosis and intervention, potentially delaying disease progression.
Related Concept Videos
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Marcia's Theory of Identity Status
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Parkinson's Disease: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

